Grapefruit USA Inc (GPFT)

[TASHI]

Lately, I've been wondering what type of interaction occurred between Imaging3 and the major companies at the RSNA. I'm sure Dean can only provide limited information here...

It's my understanding that Dean met with about 5 major companies including Stryker, which sent an entire team out to meet with him. Toshiba was next door and visited I3 often.

There is an indication of interest in the Dominion in follow up meetings with Toshiba & Stryker to occur this month, and possibly other companies next month. These are good signs to me since it's understood the DVIS does not have complete FDA approval.

Also, I don't remember Stryker being heavily involved in Imaging as with the other major companies such as GE, Phillips, Siemens and Toshiba.

http://www.stryker.com/en-us/Solutions/Imaging/index.htm

A year ago, I agreed with various opinions on this board that IMGG would need complete FDA approval, in order for the stock to begin that upward movement. However, I'm am not so sure that should be the case during this current economic downturn when comparing the costs of the Dominion v. CT.

My thoughts revolve around the Dominion's versatility with patented real-time 3D, low dose radiation, small foot-print and mobility. With a low price per unit cost, I imagine the upgraded software has helped tremendously in packaging a complete product.

Whether it be partnering or a buy-out of Imaging3, why would one of the majors need to wait for FDA clearance to take a chance on the DVIS?

There is potential here for one of the majors to get a jump on their competition. It appears to me that if Stryker is looking for a strong presence in imaging, why not go after the Dominion?

(Just my speculation)